Table 2 Summary of Imaging Findings in HIV− and HIV + subjects.
Parameters | HIV−patients with documented CNS cryptococcosis (n = 45) | HIV−patients with pulmonary nut no CNS cryptococcosis (n = 5) | HIV + patients with documented CNS cryptococcosis (n = 11) |
|---|---|---|---|
Enhancing basal ganglia lesions | 13 (28.9%) | 0 (0%) | 4 (36.4%) |
Non-enhancing basal ganglia lesions (prominent perivascular spaces) | 25 (55.6%) | 1 (20%) | 5 (45.5%) |
Other parenchymal enhancing lesions | 22 (48.9%) | 0 (0%) | 3 (27.3%) |
Ependymitis | 16 (35.6%) | 0 (0%) | 0 (0%) |
Choroid plexitis | 13 (28.9%) | 0 (0%) | 0 (0%) |
Meningeal (pial) enhancement | 32 (71.1%) | 0 (0%) | 9 (81.8%) |
Hydrocephalus | 23 (51.1%) | 0 (0%) | 1 (9.1%) |
